LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 2 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 2. - Dataset (ID:20310)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
---|---|---|---|---|---|---|---|---|---|---|
MCF 10A-H2B-mCherry | Neratinib | 0.56234 | 82.85 | 17.25 | 210 | 5861 | 0.0358 | 0.3461 | MN20160310_N02 | K12 |
MCF 10A-H2B-mCherry | Neratinib | 0.56234 | 82.85 | 17.25 | 982 | 5861 | 0.1675 | 0.6172 | MN20160310_N02 | K12 |
MCF 10A-H2B-mCherry | Neratinib | 0.56234 | 82.85 | 17.25 | 147 | 5861 | 0.0251 | 0.2902 | MN20160310_N02 | M11 |
MCF 10A-H2B-mCherry | Neratinib | 0.56234 | 82.85 | 17.25 | 1211 | 5861 | 0.2066 | 0.6580 | MN20160310_N02 | M11 |
MCF 10A-H2B-mCherry | Neratinib | 0.56234 | 84.82 | 17.25 | 213 | 5924 | 0.0360 | 0.3477 | MN20160310_N02 | K12 |
MCF 10A-H2B-mCherry | Neratinib | 0.56234 | 84.82 | 17.25 | 1007 | 5924 | 0.1700 | 0.6206 | MN20160310_N02 | K12 |
MCF 10A-H2B-mCherry | Neratinib | 0.56234 | 84.82 | 17.25 | 141 | 5924 | 0.0238 | 0.2833 | MN20160310_N02 | M11 |
MCF 10A-H2B-mCherry | Neratinib | 0.56234 | 84.82 | 17.25 | 1261 | 5924 | 0.2129 | 0.6644 | MN20160310_N02 | M11 |
MCF 10A-H2B-mCherry | Neratinib | 0.56234 | 86.79 | 17.25 | 169 | 6008 | 0.0281 | 0.3103 | MN20160310_N02 | K12 |
MCF 10A-H2B-mCherry | Neratinib | 0.56234 | 86.79 | 17.25 | 1038 | 6008 | 0.1728 | 0.6245 | MN20160310_N02 | K12 |
MCF 10A-H2B-mCherry | Neratinib | 0.56234 | 86.79 | 17.25 | 120 | 6008 | 0.0200 | 0.2582 | MN20160310_N02 | M11 |
MCF 10A-H2B-mCherry | Neratinib | 0.56234 | 86.79 | 17.25 | 1191 | 6008 | 0.1982 | 0.6512 | MN20160310_N02 | M11 |
MCF 10A-H2B-mCherry | Neratinib | 0.56234 | 88.76 | 17.25 | 173 | 6047 | 0.0286 | 0.3135 | MN20160310_N02 | K12 |
MCF 10A-H2B-mCherry | Neratinib | 0.56234 | 88.76 | 17.25 | 954 | 6047 | 0.1577 | 0.6075 | MN20160310_N02 | K12 |
MCF 10A-H2B-mCherry | Neratinib | 0.56234 | 88.76 | 17.25 | 80 | 6047 | 0.0132 | 0.1990 | MN20160310_N02 | M11 |
MCF 10A-H2B-mCherry | Neratinib | 0.56234 | 88.76 | 17.25 | 1127 | 6047 | 0.1863 | 0.6395 | MN20160310_N02 | M11 |
MCF 10A-H2B-mCherry | Neratinib | 0.56234 | 90.74 | 17.25 | 171 | 6109 | 0.0280 | 0.3111 | MN20160310_N02 | K12 |
MCF 10A-H2B-mCherry | Neratinib | 0.56234 | 90.74 | 17.25 | 1013 | 6109 | 0.1658 | 0.6176 | MN20160310_N02 | K12 |
MCF 10A-H2B-mCherry | Neratinib | 0.56234 | 90.74 | 17.25 | 79 | 6109 | 0.0129 | 0.1968 | MN20160310_N02 | M11 |
MCF 10A-H2B-mCherry | Neratinib | 0.56234 | 90.74 | 17.25 | 1228 | 6109 | 0.2010 | 0.6548 | MN20160310_N02 | M11 |
MCF 10A-H2B-mCherry | Neratinib | 0.56234 | 92.71 | 17.25 | 136 | 6184 | 0.0220 | 0.2755 | MN20160310_N02 | K12 |
MCF 10A-H2B-mCherry | Neratinib | 0.56234 | 92.71 | 17.25 | 1022 | 6184 | 0.1653 | 0.6177 | MN20160310_N02 | K12 |
MCF 10A-H2B-mCherry | Neratinib | 0.56234 | 92.71 | 17.25 | 79 | 6184 | 0.0128 | 0.1964 | MN20160310_N02 | M11 |
MCF 10A-H2B-mCherry | Neratinib | 0.56234 | 92.71 | 17.25 | 1278 | 6184 | 0.2067 | 0.6609 | MN20160310_N02 | M11 |
MCF 10A-H2B-mCherry | Neratinib | 0.56234 | 94.68 | 17.25 | 67 | 6239 | 0.0107 | 0.1731 | MN20160310_N02 | K12 |